Antiplatelet therapy and platelet function testing
Department of Pediatrics
Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Blood Platelets; *Drug Resistance; Humans; Platelet Aggregation Inhibitors; *Platelet Function Tests; Stents; Thrombosis; Treatment Outcome
Hematology | Oncology | Pediatrics
Conclusion: The use of combination antiplatelet therapy with aspirin (ASA) and a thienopyridine has resulted in improved clinical outcomes in patients with acute coronary syndromes (ACS) and in those who undergo percutaneous coronary interventions (PCI). The most appropriate dose of thienopyridine therapy and its optimal duration of pretreatment and administration post-PCI remain unknown. ...
DOI of Published Version
Clin Cardiol. 2008 Mar;31(3 Suppl 1):I36. doi 10.1002/clc.20371
Braunwald E, Angiolillo DJ, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel PA, Michelson AD, Peterson ED, Wiviott SD. (2008). Antiplatelet therapy and platelet function testing. Hematology/Oncology. https://doi.org/10.1002/clc.20371. Retrieved from https://escholarship.umassmed.edu/peds_hematology/104